USPTO serial 90728626
OTSUKA HEALTHCARE ANALYTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 9, 2023
- Examiner
- CORDOVA, RAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OTSUKA HEALTHCARE ANALYTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Otsuka Pharmaceutical Co., Ltd.
Chiyoda-ku, Tokyo, JP
Otsuka Pharmaceutical Co., Ltd.
Chiyoda-ku, Tokyo, JP
Otsuka Pharmaceutical Co., Ltd.
Chiyoda-ku, Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott S. Havlick
Scott S. Havlick HOLLAND & HART LLPP.O. BOX 8749ATTN: TRADEMARK DOCKETINGDENVER, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computers; computer hardware; downloadable and recorded computer software for use in controlling the operation and execution of programs and networks; downloadable and recorded computer software for use in connecting disparate computer systems, servers and storage devices; downloadable and recorded computer software for managing hardware, software, and processes that exist within an information technology environment, namely, operating and application systems software, and instruction manuals sold as a unit therewith; downloadable and recorded computer programs for use in collecting, managing, analyzing, storing, sharing, and comparing medical information, patient records, and patient data and reporting on the same | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, sensor patches attached to the patient's body for use in measuring, collecting, transmitting, and storing patient data and medical information such as drug ingestion information, pulse, heart rate, respiratory rate, body temperature, electric pressure in the body, human motion, human position or sleeping condition; Medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; Medical device, namely, a device for measuring body position during sleep, all of the above for supporting treatment decision based on medical information, patient records, and patient data and providing that information in an actionable form to end users | ACTIVE | — |
| 035 | Business management consulting services and business consulting services; business information; data processing management services; database management; compilation and systemization of information into computer databases; data analytics service | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable computer software for use in controlling the operation and execution of programs and networks; providing temporary use of non-downloadable computer software for use in connecting disparate computer systems, servers and storage devices; providing temporary use of non-downloadable computer software for managing hardware, software, and processes that exist within an information technology environment, namely, operating and application systems software, and instruction manuals sold as a unit therewith; design and development of computer software; computer programming; database design and development; providing temporary use of non-downloadable computer programs for use in collecting, managing, analyzing, storing, sharing, and comparing medical information, patient records, and patient data and reporting on the same | ACTIVE | — |
| 044 | Providing medical information, patient records and patient data for supporting clinician determined decision making; providing medical information, consultancy and advisory services; health care consultancy services; maintaining personal medical history records and files; healthcare analytics services in the nature of providing an internet-based database of patient medical information, patient records, and patient data; medical reporting services, namely, compilation of medical reports | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named OTSUKA HEALTHCARE ANALYTICS
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 9, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 9, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 18, 2023 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 11, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 10, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 10, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 10, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 10, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 10, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 3, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 22, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 15, 2022 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 29, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 29, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 22, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Nov 5, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 4, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 18, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 11, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 23, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 19, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 12, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 12, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 12, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 7, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |